Overview

Feasibility Study for Repurposing RET Inhibitors

Status:
NOT_YET_RECRUITING

Trial end date:
2028-04-23

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effects of selpercatinib on cachexia and anorexia in patients diagnosed with NSCLC, colorectal cancer, or pancreatic cancer.

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

University of Oklahoma

Collaborator:

Presbyterian Health Foundation

Treatments:

selpercatinib